Sweden Seeks Aid Abroad

STOCKHOLM—The two largest biotechnology companies in Sweden have set up foreign research centers to compensate for a shortage of trained scientists at home. Pharmacia is developing a center for genetic engineering research in La Jolla, Calif., while Astra has recently opened a research facility in Bangalore, India. Both centers will be staffed by local scientists. "We cannot find the right people here in Sweden," said Sune Rosell, head of research and development for Astra. The company pla

Written bySara Webb
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Pharmacia is developing a center for genetic engineering research in La Jolla, Calif., while Astra has recently opened a research facility in Bangalore, India. Both centers will be staffed by local scientists.

"We cannot find the right people here in Sweden," said Sune Rosell, head of research and development for Astra. The company placed advertisements in the scientific press aimed specifically at Indian researchers in the recombinant DNA and molecular biology field, and received about 100 replies. "In Sweden," Rosell said, "the same advertisement would have brought in about 10 applicants."

Astra's new facility will concentrate on research into DNA techniques, cloning and protein chemistry, areas it has been unable to pursue for want of research expertise in Sweden. Its scientists have begun to look into DNA probes to speed up diagnosis of different kinds of diarrhea. The company has spent more than $5 million on the project, and expects ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies